Skip to main content
Cancer Explained
Beginner 7 min readSource verified

ALL: Pathology and Molecular Results

How pathology, blood, marrow, chromosome, and molecular results help classify Acute Lymphoblastic Leukemia (ALL) and shape the next discussion.

AI-assisted and source verified. Not reviewed by a healthcare professional unless specifically stated.

Sources last checked: 2026-07-22Last updated: 2026-07-22Next planned review: 2027-07-22

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status — Source verified. This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Our editorial processHow we use AIReport an error

NCI source

National Cancer Institute — Acute Lymphoblastic Leukemia (ALL)

ALL: Pathology and Molecular Results

The short answer

Evaluation may include blood and marrow examination, immunophenotyping, chromosome and molecular testing, and CNS assessment. Each result should answer a specific diagnostic, risk, or treatment question.

  • Evaluation may include blood and marrow examination, immunophenotyping, chromosome and molecular testing, and CNS assessment.

  • Planning may depend on B- or T-cell type, Philadelphia chromosome or other findings, age, health, CNS involvement, and response.

  • A result can be diagnostic, prognostic, predictive, or useful for monitoring—and these are not identical roles.

  • Ask which results are confirmed and which remain pending.

Choose how you want to understand this

The full explanation.

What the testing must establish

The diagnostic work may include blood and marrow examination, immunophenotyping, chromosome and molecular testing, and CNS assessment. The goal is to name the disease precisely, distinguish it from look-alikes, describe biologic or risk features, and create a baseline for response monitoring.

Give each result a job

Ask whether a finding confirms the diagnosis, estimates disease behavior, predicts response to a particular treatment, or tracks response over time. One finding may do more than one job, but no result should be interpreted without context.

For Acute Lymphoblastic Leukemia (ALL), planning may depend on B- or T-cell type, Philadelphia chromosome or other findings, age, health, CNS involvement, and response. Ask the clinician to point to the report language supporting each conclusion.

Blood, marrow, and tissue are not interchangeable

Different samples answer different questions. Ask which sample was tested, whether it was adequate, what method was used, and whether comparison with future samples will use the same laboratory or scale.

Leave with a results map

Create four columns: confirmed diagnosis, risk or treatment features, monitoring markers, and pending results. Add who will communicate each pending result and when. No news should not be treated as a normal result.

Words to know

Tap any term to see what it means.

Browse the full glossary →

Common questions

Why are so many tests needed?

Blood cancers can look similar while differing in cell type, biology, pace, and treatment response.

Does one gene result determine treatment?

Usually not by itself. The team interprets it with the full diagnosis, disease status, health, and treatment goals.

What is measurable residual disease?

It is sensitive testing for disease remaining after treatment; its meaning and use vary by blood cancer and test.

Can results be reviewed elsewhere?

You can ask whether specialist hematopathology review would increase confidence or change planning.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Turn this guide into a short list for your care team.

Build questions for your visit
Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Check Your Understanding

Check Your Understanding

0 of 3 answered

  1. Q1.What is the safest purpose of this guide?
  2. Q2.What information should guide the next step?
  3. Q3.What is a useful next question?

This self-assessment checks understanding of educational content only. It is not medical advice. Open this review on its own page.

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status: Source verified This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Related learning map

How this explanation connects to 10 other things you can explore — related topics, terms, questions, practice, and its NCI source.

ALL: Pathology and Molecular Results